GlaxoSmithKline Consumer Healthcare Financial Results- Aug 01, 2013

Press Release
Gurgaon, NCR India, August 1, 2013
GlaxoSmithKline Consumer Healthcare Ltd records high growth for the quarter ended June 30, 2013

  • Sales up by 17 %

  • Net Profits up by 12.5 %

  • Net Profits up by 12.5 %


GlaxoSmithKline Consumer Healthcare Limited (GSKCH) today declared its financial results for the quarter ended June 30, 2013. Net sales at Rs 853 crores recorded a growth of 17 % over 2012 with PBT at Rs. 182 crores growing by 15 % for the same period and PAT at Rs 120 crores growing by 12.5 %.

Commenting on the Company’s performance, Mr. Zubair Ahmed, MD, GSKCH India, said, GSKCH has been recording robust growth year-on-year across portfolios. Over the last few months, we have been focusing not only on base products but also high science based value-added products, which are designed to address specific needs of the consumer. These specialised products are the next level of offering for consumers who are looking at focused benefits for their family. Products such as Women’s Horlicks, Mother’s Horlicks, Horlicks ProMind and Horlicks Nutribic, have contributed to the Company’s growth. In addition, we have also been concentrating on driving deeper penetration across categories which has also contributed to the overall growth of the brands. Furthermore, cost-efficient engineering programmes have helped the Company deliver progressive result.

India Performance

Another quarter of strong double digit profitable growth was driven by superior Sales performance and a strong cost management programme.

GSKCH is committed to top line growth and has been exceeding expectations over the last quarters by remarkably maintaining its performance.


The GSK health drink portfolio continues to be a market leader with an overall volume share of 65.2% (MAT Jun 2013).

In May this year, Horlicks has made entry into the flavoured oats segment with the launch of three new exciting flavours (Classic Masala, Southern Spices and Mild Kurma).

Portfolio expansion with the launch of Nutribic Honey & Crispy Oats biscuits in April’13.

Backed by a strong marketing and activation package, the Boost volume market share has climbed to 28.3% from 27.4% in its strong market of South (MAT Jun 2013, South U+R).

Boost launched a new campaign in April’13- ‘Boost powering Sachin’s Stamina’. The new campaign was accompanied with a packaging disruption with Sachin’s graphical image on base packs.

Oral Health Care and Wellness

Increased focus on Oral Healthcare (OHC) category in India through launch of Sensodyne Repair & Protect, in April ’13.

Over The Counter (OTC) portfolio extension of brand Eno into the liquid and tablet format in June ’13. The brand also launched a new flavour- Nimbu Shikanji in its powder format.

About GlaxoSmithKline Consumer Healthcare Ltd

GSKCH is an associate of GlaxoSmithKline plc. of U.K, a global science based healthcare company. GSKCH has continually benefited from the technical and marketing inputs that have been available as a consequence of this association. GSKCH is the largest player in the health food drinks industry. The Company with its manufacturing plants located in Nabha, Rajahmundry and Sonepat has a total workforce of about 3450 people.

GSKCH has a strong marketing and distribution network in India comprising over 650 distributors and a direct coverage of over 7,50,000 retail outlets. Its flagship product, Horlicks, is a widely regarded and highly respected brand for over 100 years. The Company also manufactures and markets Boost, Viva and Maltova and in addition markets and distributes a number of products in diverse categories, which include prominent names such as Eno, Crocin and Iodex as well as products from the global portfolio like and Sensodyne.

Media Contacts ______________________________________________________

Sakshi Mathur
Genesis Burson Marsteller 9999007585

Kuheli Ray
Genesis Burson Marsteller 9999783541